Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -750,400 | -602,600 | -668,100 | -103,500 | 98,300 |
| Depreciation Amortization | 1,322,000 | 701,200 | 504,300 | 301,200 | 684,800 |
| Income taxes - deferred | -275,000 | -170,000 | -137,500 | -118,000 | -221,000 |
| Accounts receivable | 19,100 | -28,700 | -46,100 | 66,700 | 371,100 |
| Other Working Capital | -163,600 | -261,100 | -251,100 | -17,200 | -80,300 |
| Other Operating Activity | 1,061,400 | 923,000 | 889,500 | 89,400 | -187,100 |
| Operating Cash Flow | $1,213,500 | $561,800 | $291,000 | $218,600 | $665,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 11,900 | N/A | 53,700 |
| PPE Investments | -170,800 | -111,500 | -67,900 | -28,100 | -129,500 |
| Net Acquisitions | -15,100 | -194,600 | -194,600 | -141,300 | -5,742,800 |
| Purchase Of Investment | 2,900 | N/A | N/A | N/A | -156,700 |
| Sale Of Investment | 37,700 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -130,000 | -5,000 | -2,400 | -2,200 | -9,000 |
| Other Investing Activity | -130,000 | 20,000 | -2,400 | -2,200 | 226,300 |
| Investing Cash Flow | $-275,300 | $-286,100 | $-253,000 | $-171,600 | $-5,749,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 125,000 | 125,000 | 75,000 | 375,000 |
| Debt Issued | 2,437,300 | N/A | -216,700 | N/A | 5,665,500 |
| Debt Repayment | -3,229,500 | -260,600 | -2,200 | -97,100 | -679,700 |
| Common Stock Issued | 37,600 | 44,000 | 5,500 | 3,200 | 18,800 |
| Common Stock Repurchased | -170,000 | -165,400 | -22,500 | -21,900 | -16,100 |
| Other Financing Activity | 57,300 | 55,200 | 3,800 | -1,700 | -173,900 |
| Financing Cash Flow | $-867,300 | $-201,800 | $-107,100 | $-42,500 | $5,189,600 |
| Exchange Rate Effect | -23,900 | -24,900 | -23,000 | 4,900 | 3,300 |
| Beginning Cash Position | 319,000 | 319,000 | 319,000 | 319,000 | 209,300 |
| End Cash Position | 329,000 | 368,000 | 226,900 | 328,400 | 319,000 |
| Net Cash Flow | $10,000 | $49,000 | $-92,100 | $9,400 | $109,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,213,500 | 561,800 | 291,000 | 218,600 | 665,800 |
| Capital Expenditure | -177,900 | -117,400 | -73,800 | -29,200 | -137,500 |
| Free Cash Flow | 1,035,600 | 444,400 | 217,200 | 189,400 | 528,300 |